nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—SLC22A11—Furosemide—dilated cardiomyopathy	0.153	0.189	CbGbCtD
Pravastatin—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.15	0.185	CbGbCtD
Pravastatin—ABCC2—Spironolactone—dilated cardiomyopathy	0.124	0.153	CbGbCtD
Pravastatin—SLC22A8—Furosemide—dilated cardiomyopathy	0.0891	0.11	CbGbCtD
Pravastatin—ABCC2—Furosemide—dilated cardiomyopathy	0.0848	0.105	CbGbCtD
Pravastatin—SLC22A6—Furosemide—dilated cardiomyopathy	0.0621	0.0767	CbGbCtD
Pravastatin—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0598	0.0739	CbGbCtD
Pravastatin—ABCB1—Lisinopril—dilated cardiomyopathy	0.046	0.0568	CbGbCtD
Pravastatin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0405	0.05	CbGbCtD
Pravastatin—Anxiety depression—Lisinopril—dilated cardiomyopathy	0.00687	0.0466	CcSEcCtD
Pravastatin—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.00497	0.0337	CcSEcCtD
Pravastatin—Common cold—Lisinopril—dilated cardiomyopathy	0.00432	0.0293	CcSEcCtD
Pravastatin—CYP2C9—cardial valve—dilated cardiomyopathy	0.00317	0.463	CbGeAlD
Pravastatin—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00316	0.086	CbGpPWpGaD
Pravastatin—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00287	0.0781	CbGpPWpGaD
Pravastatin—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00283	0.0192	CcSEcCtD
Pravastatin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00247	0.0168	CcSEcCtD
Pravastatin—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00241	0.0656	CbGpPWpGaD
Pravastatin—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00217	0.0147	CcSEcCtD
Pravastatin—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00201	0.0137	CcSEcCtD
Pravastatin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00201	0.0548	CbGpPWpGaD
Pravastatin—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00181	0.0123	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00181	0.0123	CcSEcCtD
Pravastatin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00172	0.0116	CcSEcCtD
Pravastatin—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00171	0.0116	CcSEcCtD
Pravastatin—Heartburn—Lisinopril—dilated cardiomyopathy	0.00164	0.0111	CcSEcCtD
Pravastatin—Drug interaction—Furosemide—dilated cardiomyopathy	0.00162	0.011	CcSEcCtD
Pravastatin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0016	0.0108	CcSEcCtD
Pravastatin—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00158	0.0107	CcSEcCtD
Pravastatin—Vasculitis—Furosemide—dilated cardiomyopathy	0.00154	0.0105	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00153	0.0104	CcSEcCtD
Pravastatin—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00144	0.00975	CcSEcCtD
Pravastatin—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHA—dilated cardiomyopathy	0.00141	0.0383	CbGpPWpGaD
Pravastatin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00131	0.0089	CcSEcCtD
Pravastatin—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00128	0.00871	CcSEcCtD
Pravastatin—Viral infection—Lisinopril—dilated cardiomyopathy	0.00125	0.00847	CcSEcCtD
Pravastatin—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00124	0.00843	CcSEcCtD
Pravastatin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00123	0.00832	CcSEcCtD
Pravastatin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00122	0.00828	CcSEcCtD
Pravastatin—Deafness—Furosemide—dilated cardiomyopathy	0.00122	0.00828	CcSEcCtD
Pravastatin—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00122	0.00825	CcSEcCtD
Pravastatin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00121	0.0082	CcSEcCtD
Pravastatin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00116	0.00788	CcSEcCtD
Pravastatin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00116	0.00784	CcSEcCtD
Pravastatin—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00114	0.00775	CcSEcCtD
Pravastatin—Purpura—Furosemide—dilated cardiomyopathy	0.00113	0.00768	CcSEcCtD
Pravastatin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00112	0.0076	CcSEcCtD
Pravastatin—Malaise—Spironolactone—dilated cardiomyopathy	0.00109	0.00739	CcSEcCtD
Pravastatin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00108	0.00734	CcSEcCtD
Pravastatin—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00106	0.00718	CcSEcCtD
Pravastatin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00102	0.00689	CcSEcCtD
Pravastatin—Confusional state—Spironolactone—dilated cardiomyopathy	0.000994	0.00674	CcSEcCtD
Pravastatin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000986	0.00669	CcSEcCtD
Pravastatin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000983	0.00667	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000983	0.00667	CcSEcCtD
Pravastatin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000965	0.00655	CcSEcCtD
Pravastatin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000963	0.00653	CcSEcCtD
Pravastatin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00095	0.00644	CcSEcCtD
Pravastatin—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000946	0.00642	CcSEcCtD
Pravastatin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000937	0.00636	CcSEcCtD
Pravastatin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000934	0.00634	CcSEcCtD
Pravastatin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000933	0.00633	CcSEcCtD
Pravastatin—HMGCR—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000927	0.0252	CbGpPWpGaD
Pravastatin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000925	0.00627	CcSEcCtD
Pravastatin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000911	0.00618	CcSEcCtD
Pravastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000907	0.0247	CbGpPWpGaD
Pravastatin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000907	0.00615	CcSEcCtD
Pravastatin—Injury—Lisinopril—dilated cardiomyopathy	0.000891	0.00604	CcSEcCtD
Pravastatin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000887	0.00602	CcSEcCtD
Pravastatin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000861	0.00584	CcSEcCtD
Pravastatin—Arthritis—Lisinopril—dilated cardiomyopathy	0.000843	0.00572	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000834	0.00566	CcSEcCtD
Pravastatin—Diplopia—Lisinopril—dilated cardiomyopathy	0.000819	0.00556	CcSEcCtD
Pravastatin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000812	0.00551	CcSEcCtD
Pravastatin—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000802	0.0218	CbGpPWpGaD
Pravastatin—Urticaria—Spironolactone—dilated cardiomyopathy	0.000783	0.00531	CcSEcCtD
Pravastatin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000779	0.00529	CcSEcCtD
Pravastatin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000737	0.005	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000737	0.005	CcSEcCtD
Pravastatin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000732	0.00497	CcSEcCtD
Pravastatin—Visual impairment—Furosemide—dilated cardiomyopathy	0.000728	0.00494	CcSEcCtD
Pravastatin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000726	0.00493	CcSEcCtD
Pravastatin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000714	0.00484	CcSEcCtD
Pravastatin—Influenza—Lisinopril—dilated cardiomyopathy	0.000708	0.0048	CcSEcCtD
Pravastatin—Tinnitus—Furosemide—dilated cardiomyopathy	0.000704	0.00478	CcSEcCtD
Pravastatin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000701	0.00475	CcSEcCtD
Pravastatin—SLC16A1—Basigin interactions—ITGB1—dilated cardiomyopathy	0.000699	0.019	CbGpPWpGaD
Pravastatin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000698	0.00473	CcSEcCtD
Pravastatin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000694	0.00471	CcSEcCtD
Pravastatin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000689	0.00468	CcSEcCtD
Pravastatin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000689	0.00468	CcSEcCtD
Pravastatin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000675	0.00458	CcSEcCtD
Pravastatin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000674	0.00458	CcSEcCtD
Pravastatin—Dysuria—Lisinopril—dilated cardiomyopathy	0.000662	0.00449	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000658	0.00446	CcSEcCtD
Pravastatin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000652	0.00442	CcSEcCtD
Pravastatin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000652	0.00442	CcSEcCtD
Pravastatin—Flatulence—Furosemide—dilated cardiomyopathy	0.000648	0.00439	CcSEcCtD
Pravastatin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000646	0.00438	CcSEcCtD
Pravastatin—Weight increased—Lisinopril—dilated cardiomyopathy	0.000644	0.00437	CcSEcCtD
Pravastatin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000644	0.00437	CcSEcCtD
Pravastatin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00064	0.00434	CcSEcCtD
Pravastatin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000633	0.0172	CbGpPWpGaD
Pravastatin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000632	0.00429	CcSEcCtD
Pravastatin—Depression—Lisinopril—dilated cardiomyopathy	0.000629	0.00427	CcSEcCtD
Pravastatin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000627	0.00425	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000626	0.00424	CcSEcCtD
Pravastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000625	0.017	CbGpPWpGaD
Pravastatin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000622	0.00422	CcSEcCtD
Pravastatin—Rash—Spironolactone—dilated cardiomyopathy	0.000622	0.00422	CcSEcCtD
Pravastatin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000621	0.00421	CcSEcCtD
Pravastatin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000621	0.0169	CbGpPWpGaD
Pravastatin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000619	0.0042	CcSEcCtD
Pravastatin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000619	0.0042	CcSEcCtD
Pravastatin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000619	0.0042	CcSEcCtD
Pravastatin—Headache—Spironolactone—dilated cardiomyopathy	0.000618	0.00419	CcSEcCtD
Pravastatin—Jaundice—Lisinopril—dilated cardiomyopathy	0.000615	0.00417	CcSEcCtD
Pravastatin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000613	0.00416	CcSEcCtD
Pravastatin—Anaemia—Furosemide—dilated cardiomyopathy	0.000607	0.00412	CcSEcCtD
Pravastatin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000592	0.00402	CcSEcCtD
Pravastatin—Vertigo—Furosemide—dilated cardiomyopathy	0.000591	0.00401	CcSEcCtD
Pravastatin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000588	0.00399	CcSEcCtD
Pravastatin—Nausea—Spironolactone—dilated cardiomyopathy	0.000586	0.00397	CcSEcCtD
Pravastatin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000575	0.0156	CbGpPWpGaD
Pravastatin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000568	0.00385	CcSEcCtD
Pravastatin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000567	0.00384	CcSEcCtD
Pravastatin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000562	0.00381	CcSEcCtD
Pravastatin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SDHA—dilated cardiomyopathy	0.000546	0.0149	CbGpPWpGaD
Pravastatin—SLC16A1—cardiac ventricle—dilated cardiomyopathy	0.000543	0.0793	CbGeAlD
Pravastatin—Confusional state—Furosemide—dilated cardiomyopathy	0.000541	0.00367	CcSEcCtD
Pravastatin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000536	0.00364	CcSEcCtD
Pravastatin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000536	0.00363	CcSEcCtD
Pravastatin—HMGCR—TOR Signaling—RPS6KB1—dilated cardiomyopathy	0.000531	0.0145	CbGpPWpGaD
Pravastatin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000528	0.00358	CcSEcCtD
Pravastatin—Flushing—Lisinopril—dilated cardiomyopathy	0.000526	0.00357	CcSEcCtD
Pravastatin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000525	0.00356	CcSEcCtD
Pravastatin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000519	0.00352	CcSEcCtD
Pravastatin—HMGCR—myocardium—dilated cardiomyopathy	0.000518	0.0758	CbGeAlD
Pravastatin—Anorexia—Furosemide—dilated cardiomyopathy	0.000511	0.00347	CcSEcCtD
Pravastatin—SLC16A1—myocardium—dilated cardiomyopathy	0.000511	0.0746	CbGeAlD
Pravastatin—Chills—Lisinopril—dilated cardiomyopathy	0.000508	0.00345	CcSEcCtD
Pravastatin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000506	0.00343	CcSEcCtD
Pravastatin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000501	0.0034	CcSEcCtD
Pravastatin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000486	0.0033	CcSEcCtD
Pravastatin—Tension—Lisinopril—dilated cardiomyopathy	0.000484	0.00328	CcSEcCtD
Pravastatin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000483	0.00328	CcSEcCtD
Pravastatin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000483	0.0131	CbGpPWpGaD
Pravastatin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000482	0.00327	CcSEcCtD
Pravastatin—HMGCR—TOR Signaling—RAC1—dilated cardiomyopathy	0.00048	0.0131	CbGpPWpGaD
Pravastatin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000479	0.00325	CcSEcCtD
Pravastatin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000474	0.00322	CcSEcCtD
Pravastatin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000466	0.00316	CcSEcCtD
Pravastatin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000465	0.00315	CcSEcCtD
Pravastatin—Fatigue—Furosemide—dilated cardiomyopathy	0.000462	0.00314	CcSEcCtD
Pravastatin—Tremor—Lisinopril—dilated cardiomyopathy	0.000462	0.00313	CcSEcCtD
Pravastatin—Pain—Furosemide—dilated cardiomyopathy	0.000459	0.00311	CcSEcCtD
Pravastatin—Constipation—Furosemide—dilated cardiomyopathy	0.000459	0.00311	CcSEcCtD
Pravastatin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000458	0.0031	CcSEcCtD
Pravastatin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000456	0.00309	CcSEcCtD
Pravastatin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000451	0.00306	CcSEcCtD
Pravastatin—Malaise—Lisinopril—dilated cardiomyopathy	0.000445	0.00302	CcSEcCtD
Pravastatin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000443	0.00301	CcSEcCtD
Pravastatin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000442	0.003	CcSEcCtD
Pravastatin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000441	0.00299	CcSEcCtD
Pravastatin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000439	0.00298	CcSEcCtD
Pravastatin—Cough—Lisinopril—dilated cardiomyopathy	0.00043	0.00292	CcSEcCtD
Pravastatin—Urticaria—Furosemide—dilated cardiomyopathy	0.000426	0.00289	CcSEcCtD
Pravastatin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000424	0.00288	CcSEcCtD
Pravastatin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000424	0.00288	CcSEcCtD
Pravastatin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00042	0.00285	CcSEcCtD
Pravastatin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00042	0.00285	CcSEcCtD
Pravastatin—Myalgia—Lisinopril—dilated cardiomyopathy	0.00042	0.00285	CcSEcCtD
Pravastatin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000418	0.00284	CcSEcCtD
Pravastatin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000415	0.00281	CcSEcCtD
Pravastatin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000406	0.00275	CcSEcCtD
Pravastatin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000403	0.011	CbGpPWpGaD
Pravastatin—Oedema—Lisinopril—dilated cardiomyopathy	0.000402	0.00273	CcSEcCtD
Pravastatin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000402	0.00273	CcSEcCtD
Pravastatin—Infection—Lisinopril—dilated cardiomyopathy	0.0004	0.00271	CcSEcCtD
Pravastatin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000395	0.00268	CcSEcCtD
Pravastatin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000394	0.00267	CcSEcCtD
Pravastatin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000389	0.00264	CcSEcCtD
Pravastatin—Asthenia—Furosemide—dilated cardiomyopathy	0.000385	0.00261	CcSEcCtD
Pravastatin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000384	0.0026	CcSEcCtD
Pravastatin—Pruritus—Furosemide—dilated cardiomyopathy	0.00038	0.00257	CcSEcCtD
Pravastatin—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000377	0.0103	CbGpPWpGaD
Pravastatin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000367	0.00249	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000367	0.00249	CcSEcCtD
Pravastatin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000364	0.00247	CcSEcCtD
Pravastatin—HMGCR—heart—dilated cardiomyopathy	0.000362	0.0529	CbGeAlD
Pravastatin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000361	0.00245	CcSEcCtD
Pravastatin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000359	0.00243	CcSEcCtD
Pravastatin—SLC16A1—heart—dilated cardiomyopathy	0.000356	0.0521	CbGeAlD
Pravastatin—Dizziness—Furosemide—dilated cardiomyopathy	0.000355	0.00241	CcSEcCtD
Pravastatin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000354	0.0024	CcSEcCtD
Pravastatin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00035	0.00237	CcSEcCtD
Pravastatin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000347	0.00235	CcSEcCtD
Pravastatin—Constipation—Lisinopril—dilated cardiomyopathy	0.000344	0.00233	CcSEcCtD
Pravastatin—Pain—Lisinopril—dilated cardiomyopathy	0.000344	0.00233	CcSEcCtD
Pravastatin—Vomiting—Furosemide—dilated cardiomyopathy	0.000341	0.00231	CcSEcCtD
Pravastatin—Rash—Furosemide—dilated cardiomyopathy	0.000338	0.00229	CcSEcCtD
Pravastatin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000338	0.00229	CcSEcCtD
Pravastatin—Headache—Furosemide—dilated cardiomyopathy	0.000336	0.00228	CcSEcCtD
Pravastatin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000332	0.00225	CcSEcCtD
Pravastatin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000329	0.00223	CcSEcCtD
Pravastatin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00032	0.00217	CcSEcCtD
Pravastatin—Nausea—Furosemide—dilated cardiomyopathy	0.000319	0.00216	CcSEcCtD
Pravastatin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000318	0.00216	CcSEcCtD
Pravastatin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000318	0.00216	CcSEcCtD
Pravastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000318	0.00865	CbGpPWpGaD
Pravastatin—HMGCR—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000316	0.0086	CbGpPWpGaD
Pravastatin—HMGCR—cardiac atrium—dilated cardiomyopathy	0.00031	0.0452	CbGeAlD
Pravastatin—SLCO2B1—heart—dilated cardiomyopathy	0.000307	0.0448	CbGeAlD
Pravastatin—SLC16A1—cardiac atrium—dilated cardiomyopathy	0.000305	0.0445	CbGeAlD
Pravastatin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000297	0.00201	CcSEcCtD
Pravastatin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000289	0.00196	CcSEcCtD
Pravastatin—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000288	0.00783	CbGpPWpGaD
Pravastatin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000285	0.00193	CcSEcCtD
Pravastatin—SLC16A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000282	0.00768	CbGpPWpGaD
Pravastatin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000275	0.00187	CcSEcCtD
Pravastatin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000266	0.00181	CcSEcCtD
Pravastatin—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000261	0.00711	CbGpPWpGaD
Pravastatin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000256	0.00174	CcSEcCtD
Pravastatin—Rash—Lisinopril—dilated cardiomyopathy	0.000254	0.00172	CcSEcCtD
Pravastatin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000254	0.00172	CcSEcCtD
Pravastatin—Headache—Lisinopril—dilated cardiomyopathy	0.000252	0.00171	CcSEcCtD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000249	0.00678	CbGpPWpGaD
Pravastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000248	0.00675	CbGpPWpGaD
Pravastatin—Nausea—Lisinopril—dilated cardiomyopathy	0.000239	0.00162	CcSEcCtD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000234	0.00637	CbGpPWpGaD
Pravastatin—SLC16A1—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.000232	0.00633	CbGpPWpGaD
Pravastatin—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000221	0.00601	CbGpPWpGaD
Pravastatin—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000219	0.00597	CbGpPWpGaD
Pravastatin—HMGCR—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000208	0.00568	CbGpPWpGaD
Pravastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000204	0.00555	CbGpPWpGaD
Pravastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000195	0.0053	CbGpPWpGaD
Pravastatin—ABCG2—heart—dilated cardiomyopathy	0.000192	0.028	CbGeAlD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000191	0.0052	CbGpPWpGaD
Pravastatin—HMGCR—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000188	0.00511	CbGpPWpGaD
Pravastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000184	0.005	CbGpPWpGaD
Pravastatin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000183	0.00499	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00018	0.0049	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00018	0.00489	CbGpPWpGaD
Pravastatin—CYP2C9—heart—dilated cardiomyopathy	0.000175	0.0256	CbGeAlD
Pravastatin—SLC16A1—Hemostasis—TTN—dilated cardiomyopathy	0.00017	0.00464	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000169	0.00461	CbGpPWpGaD
Pravastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000167	0.00454	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000166	0.00452	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000161	0.00439	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000161	0.00439	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000152	0.00415	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00015	0.00409	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00015	0.00409	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00015	0.00408	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—ACTN2—dilated cardiomyopathy	0.000148	0.00402	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000147	0.00401	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000146	0.00398	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000146	0.00398	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000143	0.0039	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000143	0.0039	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000141	0.00384	CbGpPWpGaD
Pravastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000141	0.00383	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000136	0.00371	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000136	0.0037	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000133	0.00363	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000133	0.00361	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000133	0.00361	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00013	0.00353	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000128	0.0035	CbGpPWpGaD
Pravastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000127	0.00345	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000126	0.00343	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000126	0.00343	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—VCL—dilated cardiomyopathy	0.000126	0.00342	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000123	0.00336	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000121	0.00329	CbGpPWpGaD
Pravastatin—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000119	0.00325	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000117	0.00319	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000115	0.00312	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000112	0.00304	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000112	0.00304	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—ANKRD1—dilated cardiomyopathy	0.000111	0.00302	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000107	0.00291	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—TAZ—dilated cardiomyopathy	0.000104	0.00284	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000104	0.00282	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000102	0.00277	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.9e-05	0.0027	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.9e-05	0.0027	CbGpPWpGaD
Pravastatin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.71e-05	0.00264	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—ANKRD1—dilated cardiomyopathy	9.69e-05	0.00264	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.57e-05	0.0026	CbGpPWpGaD
Pravastatin—ABCB1—heart—dilated cardiomyopathy	9.45e-05	0.0138	CbGeAlD
Pravastatin—HMGCR—Metabolism—SDHA—dilated cardiomyopathy	9.43e-05	0.00257	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.31e-05	0.00253	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.31e-05	0.00253	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.27e-05	0.00252	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.2e-05	0.00251	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—TAZ—dilated cardiomyopathy	9.11e-05	0.00248	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.01e-05	0.00245	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.01e-05	0.00245	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	8.98e-05	0.00245	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.7e-05	0.00237	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.65e-05	0.00236	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	8.52e-05	0.00232	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.47e-05	0.0023	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.47e-05	0.0023	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.38e-05	0.00228	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—SDHA—dilated cardiomyopathy	8.24e-05	0.00224	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.06e-05	0.00219	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ANKRD1—dilated cardiomyopathy	8.01e-05	0.00218	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	8.01e-05	0.00218	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.87e-05	0.00214	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.84e-05	0.00213	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.84e-05	0.00213	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—TAZ—dilated cardiomyopathy	7.53e-05	0.00205	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	7.53e-05	0.00205	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.38e-05	0.00201	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.29e-05	0.00198	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	7.24e-05	0.00197	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	7e-05	0.0019	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.94e-05	0.00189	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	6.93e-05	0.00189	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—SDHA—dilated cardiomyopathy	6.81e-05	0.00185	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	6.75e-05	0.00184	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	6.69e-05	0.00182	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—ITGB1—dilated cardiomyopathy	6.3e-05	0.00172	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	6.29e-05	0.00171	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.01e-05	0.00164	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.75e-05	0.00156	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	5.72e-05	0.00156	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	5.69e-05	0.00155	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.65e-05	0.00154	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.6e-05	0.00152	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	5.38e-05	0.00146	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—CD36—dilated cardiomyopathy	5.38e-05	0.00146	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	5.3e-05	0.00144	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—RAC1—dilated cardiomyopathy	5.07e-05	0.00138	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.04e-05	0.00137	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	4.98e-05	0.00136	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	4.86e-05	0.00132	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	4.5e-05	0.00123	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.42e-05	0.0012	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.36e-05	0.00119	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.3e-05	0.00117	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.24e-05	0.00115	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.24e-05	0.00115	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.16e-05	0.00113	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.05e-05	0.0011	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.94e-05	0.00107	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.87e-05	0.00105	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	3.8e-05	0.00103	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.64e-05	0.000992	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	3.57e-05	0.000971	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.47e-05	0.000945	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.45e-05	0.00094	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.38e-05	0.00092	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—RAF1—dilated cardiomyopathy	3.36e-05	0.000914	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.33e-05	0.000906	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.29e-05	0.000895	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.27e-05	0.000891	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.26e-05	0.000889	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	3.23e-05	0.000879	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.09e-05	0.000841	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.04e-05	0.000828	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.97e-05	0.000808	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.96e-05	0.000807	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.91e-05	0.000792	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.89e-05	0.000787	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.86e-05	0.00078	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.86e-05	0.00078	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	2.8e-05	0.000761	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.7e-05	0.000735	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.69e-05	0.000733	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.69e-05	0.000732	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.68e-05	0.000728	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.6e-05	0.000708	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—GPX1—dilated cardiomyopathy	2.56e-05	0.000697	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.56e-05	0.000696	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.54e-05	0.000691	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.52e-05	0.000685	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—CD36—dilated cardiomyopathy	2.49e-05	0.000679	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.44e-05	0.000663	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.29e-05	0.000625	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.28e-05	0.000619	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.26e-05	0.000616	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—AGT—dilated cardiomyopathy	2.25e-05	0.000611	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—GPX1—dilated cardiomyopathy	2.24e-05	0.000609	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—CD36—dilated cardiomyopathy	2.18e-05	0.000593	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.16e-05	0.000589	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.01e-05	0.000547	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	1.97e-05	0.000535	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—AGT—dilated cardiomyopathy	1.96e-05	0.000534	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	1.92e-05	0.000521	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.89e-05	0.000514	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	1.85e-05	0.000504	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.83e-05	0.000498	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CD36—dilated cardiomyopathy	1.8e-05	0.000491	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.76e-05	0.00048	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	1.72e-05	0.000469	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.72e-05	0.000467	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.71e-05	0.000464	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.66e-05	0.000452	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.66e-05	0.000452	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—AGT—dilated cardiomyopathy	1.62e-05	0.000442	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.59e-05	0.000433	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.55e-05	0.000421	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.5e-05	0.00041	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.5e-05	0.000408	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.5e-05	0.000407	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.48e-05	0.000404	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.41e-05	0.000385	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.39e-05	0.000378	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	1.36e-05	0.000369	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.35e-05	0.000368	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.32e-05	0.00036	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.29e-05	0.00035	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.22e-05	0.000333	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.22e-05	0.000331	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.19e-05	0.000324	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.16e-05	0.000315	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.07e-05	0.000292	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	8.77e-06	0.000239	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.6e-06	0.000234	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	8.54e-06	0.000232	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	7.69e-06	0.000209	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	7.59e-06	0.000207	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	7.4e-06	0.000201	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	6.66e-06	0.000181	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	6.62e-06	0.00018	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	6.44e-06	0.000175	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.23e-06	0.00017	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.18e-06	0.000168	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.07e-06	0.000165	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.02e-06	0.000164	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	5.8e-06	0.000158	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.47e-06	0.000149	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.42e-06	0.000148	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.08e-06	0.000111	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.97e-06	0.000108	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.57e-06	9.73e-05	CbGpPWpGaD
